NDC 59212-601

PANRETIN

Alitretinoin

PANRETIN is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alitretinoin.

Product ID59212-601_1629bcf4-47bc-4203-878f-c7daeb6e8fc7
NDC59212-601
Product TypeHuman Prescription Drug
Proprietary NamePANRETIN
Generic NameAlitretinoin
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-09-10
Marketing CategoryNDA / NDA
Application NumberNDA020886
Labeler NameConcordia Pharmaceuticals Inc.
Substance NameALITRETINOIN
Active Ingredient Strength60 mg/60g
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59212-601-22

60 g in 1 TUBE (59212-601-22)
Marketing Start Date2019-09-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59212-601-22 [59212060122]

PANRETIN GEL
Marketing CategoryNDA
Application NumberNDA020886
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-09-10

Drug Details

Active Ingredients

IngredientStrength
ALITRETINOIN60 mg/60g

OpenFDA Data

SPL SET ID:49c16717-7d86-4257-80c9-baa1417e5555
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213502
  • 313847
  • UPC Code
  • 0359212601223
  • Pharmacological Class

    • Retinoid [EPC]
    • Retinoids [CS]
    • Retinoid [EPC]
    • Retinoids [CS]

    NDC Crossover Matching brand name "PANRETIN" or generic name "Alitretinoin"

    NDCBrand NameGeneric Name
    59212-601PANRETINalitretinoin
    62856-601PanretinAlitretinoin

    Trademark Results [PANRETIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PANRETIN
    PANRETIN
    74700355 2149627 Live/Registered
    EISAI INC.
    1995-07-12

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.